Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...
From Estonia to Antarctica, this once-pagan symbol has taken on many strange forms. In December 1848, an illustration showed Queen Victoria, Prince Albert, and their children admiring a Christmas tree ...
Binary options trading offers a high-risk, high-reward way to speculate on short-term price movements. Unlike traditional options, binary options settle with a fixed payout either the trade ends “in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback